Industry Qualifies Enthusiasm For Omega-3 Qualified Health Claim
This article was originally published in The Tan Sheet
FDA's qualified health claim linking omega-3 fatty acids to coronary heart disease too narrowly interprets the beneficial relationship, dietary supplement industry stakeholders contend
You may also be interested in...
FDA should study consumer perceptions of qualified health claims by testing statements that contain both "report card" grades and text ratings, as well as claims that do not bear a letter grade, the Consumer Healthcare Products Association says in recent comments to the agency
A white paper on the "the importance of Omega-3 fatty acids for heart health" notes that following review by FDA and the American Heart Association, "when it comes to omega-3s and heart health, the evidence is strongest for EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid)," the Council for Responsible Nutrition states. The paper was released July 20 by CRN's Omega-3 Working Group. "It is important to educate various audiences on the benefits obtained from the different types of omega-3 fatty acids," according to Ian Newton, executive director of the working group. The paper "helps clarify some of the differences." FDA approved a qualified health claim for EPA and DHA in September (1"The Tan Sheet" Sept. 13, 2004, p. 12)...
More than two-thirds of fish oil marketers met the strictest U.S. manufacturing standards, according to a survey by Environmental Defense